# Tolerability and Efficacy of CBD Extract for RLS Treatment

> **NCT07224932** · PHASE2 · NOT_YET_RECRUITING · sponsor: **University of Colorado, Denver** · enrollment: 60 (estimated)

## Conditions studied

- Restless Leg Syndrome

## Interventions

- **DRUG:** BRC-002
- **DRUG:** Placecbo

## Key facts

- **NCT ID:** NCT07224932
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12-19
- **Primary completion:** 2026-01-01
- **Final completion:** 2026-02-25
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-11-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07224932

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07224932, "Tolerability and Efficacy of CBD Extract for RLS Treatment". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07224932. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*